SCHEMBL8312595

SCHEMBL8312595

C[C@H](NC(=O)C1CCN(c2cccnc2)CC1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.50
HSD17B10 Q99714 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.45
GFER P55789 2/20 0.45
NAMPT P43490 1/20 0.44
CYP46A1 Q9Y6A2 1/20 0.44
NPY5R Q15761 1/20 0.44
ITGB3 P05106 1/20 0.43
ITGA2B P08514 1/20 0.43
RAB9A P51151 2/20 0.42
ALDH1A1 P00352 2/20 0.42
LMNA P02545 1/20 0.42
NPC1 O15118 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6502064 1.00 GPR119 (0.50) GPR119HSD17B10SMN1; SMN2GFERNAMPT
SCHEMBL6499314 0.80 CHRNB2 (0.41) SMN1; SMN2NAMPTITGB3ITGA2BRAB9A
SCHEMBL5798534 0.79 NOTUM (0.59) GPR119CYP2C19
SCHEMBL8307614 0.78 GPR119 (0.47) GPR119SMN1; SMN2CYP46A1NPY5RRAB9A
SCHEMBL30664035 0.77 KDM4E (0.61) GPR119SMN1; SMN2NPY5RRAB9AALDH1A1
SCHEMBL31401347 0.77 KDM4E (0.61) GPR119SMN1; SMN2NPY5RRAB9AALDH1A1
SCHEMBL6500777 0.76 CTSA (0.41) SMN1; SMN2NAMPTCYP46A1RAB9AHPGD
SCHEMBL4392645 0.75 GPR119 (0.53) GPR119ALDH1A1
SCHEMBL31516268 0.75 NOTUM (0.71)
SCHEMBL30663949 0.75 GPR119 (0.53) GPR119ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005019200-A2 ARYL PIPERIDINE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-03-03 WO disclosed